Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporationverified

AGTC

Price:

$0.3936

Market Cap:

$0

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting centr...[Read more]

Industry

Biotechnology

IPO Date

2014-03-27

Stock Exchange

NASDAQ

Ticker

AGTC

The ROE as of November 2025 (TTM) for Applied Genetic Technologies Corporation (AGTC) is -123.91%

According to Applied Genetic Technologies Corporation’s latest financial reports and current stock price. The company's current ROE is -123.91%. This represents a change of 1.31% compared to the average of -8.79% of the last 4 quarters.

Applied Genetic Technologies Corporation (AGTC) Historical ROE (quarterly & annually)

How has AGTC ROE performed in the past?

The mean historical ROE of Applied Genetic Technologies Corporation over the last ten years is -46.33%. The current -123.91% ROE has changed 167.48% with respect to the historical average. Over the past ten years (40 quarters), AGTC's ROE was at its highest in in the September 2022 quarter at 96.71%. The ROE was at its lowest in in the June 2022 quarter at -64.36%.

Quarterly (TTM)
Annual

Average

-46.33%

Median

-21.36%

Minimum

-242.30%

Maximum

0.35%

Applied Genetic Technologies Corporation (AGTC) ROE by Quarter and Year

Discovering the peaks and valleys of Applied Genetic Technologies Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.44%

Maximum Annual ROE = 0.35%

Minimum Annual Increase = -6185.42%

Minimum Annual ROE = -242.30%

Quarterly (TTM)
Annual
YearROEChange
2022-242.30%259.54%
2021-67.39%4.29%
2020-64.62%2.44%
2019-2.55%-88.13%
2018-21.48%-6185.42%
20170.35%-127.93%
2016-1.26%-95.56%
2015-28.43%33.82%
2014-21.25%48.38%
2013-14.32%-332.88%

Applied Genetic Technologies Corporation (AGTC) Average ROE

How has AGTC ROE performed in the past?

The current ROE of Applied Genetic Technologies Corporation (AGTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-124.77%

5-year avg

-79.67%

10-year avg

-46.33%

Applied Genetic Technologies Corporation (AGTC) ROE vs. Peers

How is AGTC’s ROE compared to its peers?

Applied Genetic Technologies Corporation’s ROE is less than Marinus Pharmaceuticals, Inc. (105.28%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than Freeline Therapeutics Holdings plc (-102.94%), greater than Metacrine, Inc. (-83.52%), less than Serina Therapeutics, Inc. (522.99%), greater than Allakos Inc. (-97.39%), less than Kineta, Inc. (71.50%), greater than Angion Biomedica Corp. (-7534.48%), greater than Axcella Health Inc. (-620.40%), greater than Elevation Oncology, Inc. (-74.68%),

Build a custom stock screener for Applied Genetic Technologies Corporation (AGTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Applied Genetic Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Applied Genetic Technologies Corporation (AGTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Applied Genetic Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Applied Genetic Technologies Corporation's ROE?

How is the ROE calculated for Applied Genetic Technologies Corporation (AGTC)?

What is the highest ROE for Applied Genetic Technologies Corporation (AGTC)?

What is the 3-year average ROE for Applied Genetic Technologies Corporation (AGTC)?

What is the 5-year average ROE for Applied Genetic Technologies Corporation (AGTC)?

How does the current ROE for Applied Genetic Technologies Corporation (AGTC) compare to its historical average?